drugset / Trial / NCT00430950

Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

NCT00430950

RandomizedParallel-groupDouble-blindTreatment

Summary

The study will evaluate the blood pressure lowering effects of two different dosages of the combination of olmesartan and hydrochlorothiazide in patients with moderate or severe high blood pressure.

Timeline

Start
2007-02
Primary completion
2008-05
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 25 mg
Subject Olmesartan medoxomil Unknown 20 mg
Subject Olmesartan medoxomil Unknown 40 mg